Literature DB >> 35934228

IFN-β1b induces OAS3 to inhibit EV71 via IFN-β1b/JAK/STAT1 pathway.

Baisong Zheng1, Xiaolei Zhou1, Li Tian1, Jian Wang1, Wenyan Zhang2.   

Abstract

Enterovirus 71 (EV71) caused hand, foot and mouth disease (HFMD) is a serious threat to the health of young children. Although type I interferon (IFN-I) has been proven to control EV71 replication, the key downstream IFN-stimulated gene (ISG) remains to be clarified and investigated. Recently, we found that 2'-5'-oligoadenylate synthetases 3 (OAS3), as one of ISG of IFN-β1b, was antagonized by EV71 3C protein. Here, we confirm that OAS3 is the major determinant of IFN-β1b-mediated EV71 inhibition, which depends on the downstream constitutive RNase L activation. 2'-5'-oligoadenylate (2-5A) synthesis activity deficient mutations of OAS3 D816A, D818A, D888A, and K950A lost resistance to EV71 because they could not activate downstream RNase L. Further investigation proved that EV71 infection induced OAS3 but not RNase L expression by IFN pathway. Mechanically, EV71 or IFN-β1b-induced phosphorylation of STAT1, but not STAT3, initiated the transcription of OAS3 by directly binding to the OAS3 promoter. Our works elucidate the immune regulatory mechanism of the host OAS3/RNase L system against EV71 replication.
Copyright © 2022 The Authors. Publishing services by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  2′-5′-oligoadenylate synthetases 3 (OAS3); Enterovirus 71 (EV71); IFN-β1b; JAK/STAT; RNase L

Mesh:

Substances:

Year:  2022        PMID: 35934228      PMCID: PMC9583119          DOI: 10.1016/j.virs.2022.07.013

Source DB:  PubMed          Journal:  Virol Sin        ISSN: 1995-820X            Impact factor:   6.947


  39 in total

1.  STAT3 negatively regulates type I IFN-mediated antiviral response.

Authors:  Wei-Bei Wang; David E Levy; Chien-Kuo Lee
Journal:  J Immunol       Date:  2011-08-01       Impact factor: 5.422

2.  Role of STAT3 in type I interferon responses. Negative regulation of STAT1-dependent inflammatory gene activation.

Authors:  Hao H Ho; Lionel B Ivashkiv
Journal:  J Biol Chem       Date:  2006-03-29       Impact factor: 5.157

3.  Activation of RNase L is dependent on OAS3 expression during infection with diverse human viruses.

Authors:  Yize Li; Shuvojit Banerjee; Yuyan Wang; Stephen A Goldstein; Beihua Dong; Christina Gaughan; Robert H Silverman; Susan R Weiss
Journal:  Proc Natl Acad Sci U S A       Date:  2016-02-08       Impact factor: 11.205

Review 4.  The JAK-STAT pathway at twenty.

Authors:  George R Stark; James E Darnell
Journal:  Immunity       Date:  2012-04-20       Impact factor: 31.745

5.  Activation of RNase L by Murine Coronavirus in Myeloid Cells Is Dependent on Basal Oas Gene Expression and Independent of Virus-Induced Interferon.

Authors:  L Dillon Birdwell; Zachary B Zalinger; Yize Li; Patrick W Wright; Ruth Elliott; Kristine M Rose; Robert H Silverman; Susan R Weiss
Journal:  J Virol       Date:  2016-01-06       Impact factor: 5.103

6.  A (2'-5')An-dependent endonuclease: tissue distribution in BALB/c mice and the effects of IFN-beta treatment and anti-IFN-alpha/beta immunoglobulin on the levels of the enzyme.

Authors:  G Floyd-Smith; J S Denton
Journal:  J Interferon Res       Date:  1988-08

7.  TRANSFAC: transcriptional regulation, from patterns to profiles.

Authors:  V Matys; E Fricke; R Geffers; E Gössling; M Haubrock; R Hehl; K Hornischer; D Karas; A E Kel; O V Kel-Margoulis; D-U Kloos; S Land; B Lewicki-Potapov; H Michael; R Münch; I Reuter; S Rotert; H Saxel; M Scheer; S Thiele; E Wingender
Journal:  Nucleic Acids Res       Date:  2003-01-01       Impact factor: 16.971

Review 8.  Viral manipulation of STAT3: Evade, exploit, and injure.

Authors:  Armando Andres Roca Suarez; Nicolaas Van Renne; Thomas F Baumert; Joachim Lupberger
Journal:  PLoS Pathog       Date:  2018-03-15       Impact factor: 7.464

9.  Interferon-beta expression and type I interferon receptor signaling of hepatocytes prevent hepatic necrosis and virus dissemination in Coxsackievirus B3-infected mice.

Authors:  Wolfgang Koestner; Julia Spanier; Tanja Klause; Pia-K Tegtmeyer; Jennifer Becker; Vanessa Herder; Katharina Borst; Daniel Todt; Stefan Lienenklaus; Ingo Gerhauser; Claudia N Detje; Robert Geffers; Martijn A Langereis; Florian W R Vondran; Qinggong Yuan; Frank J M van Kuppeveld; Michael Ott; Peter Staeheli; Eike Steinmann; Wolfgang Baumgärtner; Frank Wacker; Ulrich Kalinke
Journal:  PLoS Pathog       Date:  2018-08-03       Impact factor: 6.823

10.  The TLR3/IRF1/Type III IFN Axis Facilitates Antiviral Responses against Enterovirus Infections in the Intestine.

Authors:  Rui Su; Muhammad Adnan Shereen; Xiaofeng Zeng; Yicong Liang; Wen Li; Zhihui Ruan; Yongkui Li; Weiyong Liu; Yingle Liu; Kailang Wu; Zhen Luo; Jianguo Wu
Journal:  mBio       Date:  2020-11-17       Impact factor: 7.867

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.